TSBX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $7,699,992.00
Insider Selling (Last 12 Months): $0.00

Turnstone Biologics Insider Trading History Chart

This chart shows the insider buying and selling history at Turnstone Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Turnstone Biologics Share Price & Price History

Current Price: $2.71
Price Change: +0.30 (1.20%)
As of 04/19/2024 02:08 PM ET

This chart shows the closing price history over time for TSBX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Turnstone Biologics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/25/2023Versant Ventures V, LlcMajor ShareholderBuy225,000$12.00$2,700,000.002,726,322View SEC Filing Icon  
7/20/2023Rishi GuptaDirectorBuy416,666$12.00$4,999,992.003,099,265View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Turnstone Biologics (NASDAQ:TSBX)

52.51% of Turnstone Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TSBX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Turnstone Biologics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/17/2024Kathleen S. Wright Associates Inc.42,553$0.11M0.1%N/A0.184%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.296,612$0.76M0.0%+173.1%1.285%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC116,116$0.30M0.0%N/A0.503%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.296,612$0.76M0.0%+173.1%1.284%Search for SEC Filing on Google Icon
2/15/2024PFM Health Sciences LP633,313$1.61M0.1%-58.5%2.742%Search for SEC Filing on Google Icon
2/15/2024Bridgeway Capital Management LLC59,900$0.15M0.0%N/A0.259%Search for SEC Filing on Google Icon
2/15/2024Caas Capital Management LP45,831$0.12M0.0%-40.1%0.198%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp65,072$0.17M0.0%+12.6%0.282%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.108,609$0.43M0.0%N/A0.470%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.7,524$30K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.517,648$2.04M0.4%N/A2.266%Search for SEC Filing on Google Icon
11/14/2023Eventide Asset Management LLC708,317$2.79M0.1%N/A3.101%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp57,782$0.23M0.0%N/A0.253%Search for SEC Filing on Google Icon
11/13/2023FMR LLC2,830,284$11.15M0.0%N/A12.392%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers7,830$31K0.0%N/A0.034%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.7,524$30K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.15,169$60K0.0%N/A0.066%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund18,867$74K0.0%N/A0.083%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Turnstone Biologics logo
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
Read More on Turnstone Biologics

Today's Range

Now: $2.71
Low: $2.57
High: $2.86

50 Day Range

MA: $3.15
Low: $2.10
High: $5.48

52 Week Range

Now: $2.71
Low: $1.63
High: $13.20

Volume

49,887 shs

Average Volume

177,603 shs

Market Capitalization

$62.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Turnstone Biologics?

Turnstone Biologics' top insider investors include:
  1. Rishi Gupta (Director)
  2. Versant Ventures V, Llc (Major Shareholder)
Learn More about top insider investors at Turnstone Biologics.

Who are the major institutional investors of Turnstone Biologics?

Turnstone Biologics' top institutional investors include:
  1. Kathleen S. Wright Associates Inc. — 0.18%
Learn More about top institutional investors of Turnstone Biologics stock.

Which major investors are buying Turnstone Biologics stock?

During the previous quarter, TSBX stock was purchased by institutional investors including:
  1. Kathleen S. Wright Associates Inc.
Within the last year, these company insiders have bought Turnstone Biologics stock:
  1. Rishi Gupta (Director)
  2. Versant Ventures V, Llc (Major Shareholder)
Learn More investors buying Turnstone Biologics stock.